Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 3, 2000, Pages 239-247

  Reddy, Bandaru S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORGANOSELENIUM DERIVATIVE;

CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; CONFERENCE PAPER; DIET THERAPY; DISEASE ASSOCIATION; FAT INTAKE; HUMAN; PRIORITY JOURNAL; CELL TRANSFORMATION; COLON TUMOR; DIET; DIETARY FIBER; REVIEW;

CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; COLONIC NEOPLASMS; DIET; DIETARY FATS; DIETARY FIBER; HUMANS;

EID: 0034152213     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (76)

1. World Health Organization. The World Health Report 1996. Geneva, Switzerland: WHO, 1997.
2. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer Statistics, 1999. CA Cancer J. Clin., 49: 9-31, 1999.
3. Wynder, E. L., Kajitani, T., Ishikawa, S., Dodo, H., and Takano, A. Environmental factors of cancer of colon and rectum. II. Japanese epidemiological data. Cancer (Phila.), 23: 1210-1220, 1969.
4. Reddy, B. S. Nutritional factors and colon cancer. Crit. Rev. Food Sci. Nutr., 35: 175-190, 1995.
5. World Cancer Research Fund and American Institute for Cancer Research. Food, Nutrition, and the Prevention of Cancer: a Global Perspective, pp. 216-251. Washington, DC: American Institute for Cancer Research, 1997.
6. Caygill, C. P., Charlett, A., and Hill, M. J. Fat, fish, fish oil and cancer. Br. J. Cancer, 74: 159-164, 1996.
7. Reddy, B. S. Diet and bile acids. Cancer Res., 41: 3766-3768, 1981.
8. Reddy, B. S. Diet and colon cancer: evidence from human and animal model studies. In: B. S. Reddy, L. A. Cohen (eds). Diet, Nutrition, and Cancer: A Critical Evaluation, Vol. 1, pp. 47-65. Boca Raton, FL: CRC Press, 1986.
9. Lipkin, M. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res., 48: 235-245, 1988.
10. DeRubertis, F. R., Craven, P. A., and Saito, R. Bile salt stimulation of colonic epithelial proliferation: evidence for involvement of lipoxygenase products. J. Clin. Investig., 74: 1614-1624, 1984.
11. Reddy, B. S., Simi, B., Patel, N., Aliaga, C., and Rao, C. V. Effect of amount and types of dietary fat on intestinal bacterial 7α-dehydroxylase and PI-PLC and colonic mucosal diacylglycerol kinase and PKC activities during different stages of colon tumor development. Cancer Res., 56: 2314-2320, 1996.
12. DeRubertis, F. R., and Craven, P. A. Relationship of bile salt stimulation of colonic epithelial phospholipid turnover and proliferative activity: role of activation of protein kinase C. Prev. Med., 16: 572-579, 1987.
13. 2 activities and COX metabolite formation during different stage of colon tumor promotion in male F344 rats. Cancer Res., 56: 532-537, 1996.
14. Reddy, B. S., and Sugie, S. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res., 48: 6642-6647, 1988.
15. Culp, B. R., Titus, B. J., and Lands, W. E. Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid. Prostaglandins Med., 3: 269-278, 1979.
16. Singh, J., Hamid, R., and Reddy, B. S. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res., 57: 3465-3470, 1997.
17. Eberhart, C. E., and DuBois, R. N. Eicosanoids and the gastrointestinal tract. Gastroenterology, 109: 285-301, 1995.
18. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell, 83: 493-501, 1995.
19. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110: 1259-1262, 1996.
20. Burkitt, D. P. Epidemiology of cancer of the colon and rectum. Cancer (Phila.), 28: 3-13, 1971.
21. Jensen, O. M., MacLennan, R., and Wahrendorf, J. Diet, bowel function, fecal characteristics and large bowel cancer in Denmark and Finland. Nutr. Cancer, 4: 5-19, 1982.
22. Reddy, B. S., Sharma, C., Simi, B., Engle, A., Laakso, K., Puska, P., and Korpela, R. Metabolic epidemiology of colon cancer: effect of dietary fiber on fecal mutagens and bile acids in healthy subjects. Cancer Res., 47: 644-648, 1987.
23. McKeown-Eyssen, G. E., and Bright-See, E. Dietary factors in colon cancer: international relationships. Nutr. Cancer, 6: 160-170, 1984.
24. Fuchs, C. S., Giovannucci, E. L., Colditz, G. A., Hunter, D. J., Stampfer, M. J., Rosner, B., Speizer, F. E., and Willett, W. C. Dietary fiber and the risk of colorectal cancer and adenoma in women. N. Engl. J. Med., 340: 169-176, 1999.
25. Howe, G. R., Benito, E., Castelleto, R., Esteve, J., Gallagher, R. P., Iscovich, J. M., Deng-ao, J., Kaaks, R., Kune, G. A., Kune, S., L'Abbe, A., Lee, H. P., Lee, M., Miller, A. B., Peters, R. K., Potter, J. D., Riboli, E., Slattery, M. L., Trichopoulos, D., Tuyns, A., Tzonou, A., Whittemore, A. S., Wu-Willimas, A. H., and Shu, Z. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J. Natl. Cancer Inst., 84: 1887-1896, 1992.
26. Trock, B., Lanza, E., and Greenwald, P. Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J. Natl. Cancer Inst., 82: 650-661, 1990.
27. Reddy, B., Engle, A., Katsifis, S., Simi, B., Bartram, H. P., Perrino, P., and Mahan, C. Biochemical epidemiology of colon cancer: effect of types of dietary fiber on fecal mutagens, acid, and neutral sterols in healthy subjects. Cancer Res., 49: 4629-4635, 1989.
28. Reddy, B. S., Engle, A., Simi, B., and Goldman, M. Effect of dietary fiber on colonic bacterial enzymes and bile acids in relation to colon cancer. Gastroenterology, 102: 1475-1482, 1992.
29. Reddy, B. S. Role of dietary fiber in colon cancer: an overview. Am. J. Med., 25: 16S-19S, 1999.
30. Wattenberg, L. W. Chemoprevention of cancer. Cancer Res., 45: 1-8, 1985.
31. Potter, J. D., and Steinmetz, K. Vegetables, fruit and phytoestrogens as preventive agents. Int. Agency Res. Cancer Sci. Publ., 139: 61-90, 1996.
32. Boone, C. W., Kelloff, G. J., and Freedman, L. S. Intraepithelial and post-invasive neoplasia as a stochastic continuum of clonal evolution, and its relationship to mechanisms of chemopreventive drug action. J. Cell Biochem. Suppl., 17G: 14-25, 1993.
33. Reddy, B. S., Rao, C. V., Rivenson, A., and Kelloff, G. Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res., 53: 3493-3498, 1997.
34. Rao, C. V., Tokumo, K., Kelloff, G., and Reddy, B. S. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis (Lond.), 12: 1051-1056, 1991.
35. Reddy, B. S., and Rao, C. V. Chemoprevention of colon cancer by thiol and other organosulfur compounds. In: M. T. Huang, T. Osawa, and C. T. Ho (eds.), Phytochemicals in Cancer Prevention, Vol. 546, pp. 164-172. Washington, DC: American Chemical Society, 1994.
36. Rao, C. V., Simi, B., and Reddy, B. S. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci in the rat colon. Carcinogenesis (Lond.), 14: 2219-2225. 1993.
37. Rao, C. V., Rivenson, A., Simi, B., and Reddy, B. S. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res., 55: 259-266, 1995.
38. Kawamori, T., Lubet, R., Steele, V. E., Kelloff, G. J., Kaskey, R. B., Rao, C. V., and Reddy, B. S. Chemopreventive effect of curcumin, a naturally-occurring antiinflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res., 59: 597-601, 1999.
39. Taylor, J. D. Lipoxygenase regulation of membrane expression of tumor cell glycoproteins and subsequent metastasis. Adv. Prostaglandin Thromboxane Leukotriene Res., 19: 439-443, 1989.
40. Xu, Y. X., Pindolia, K. R., Janakiraman, N., Chapman, N., and Gautam, S. C. Curcumin inhibits IL-1α and TNF-α induction of AP-1 and NF-κB DNA-binding activity in bone marrow stromal cells. Hematopathhol. Mol. Hematol., 11: 49-62, 1997.
41. Hanif, R., Qiao, L., Shiff, S. J., and Rigas, B. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J. Lab. Clin. Med., 130: 576-584, 1997.
42. Waddel, W. R., Ganser, G. F., Cerise, E. J., and Loughry, R. W. Sulindac for polyposis of the colon. Am. J. Surg., 157: 175-179, 1989.
43. Labayle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Dubamael, O., Trousset, M., and Attali, P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101: 635-639, 1991.
44. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
45. Kune, G. A., Kune, S., and Watson, L. F. Colorectal cancer risk, chronic illness, operations and medications: case-control results from the Melbourne Colorectal Cancer Study. Cancer Res., 48: 4399-4404, 1988.
46. Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Stolley, P. D., Shapiro, S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J. Natl. Cancer Inst., 83: 355-358, 1991.
47. Thun, M. H., Namboodiri, M. M., and Heath, C. W. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325: 1593-1596, 1991.
48. Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., and Willett, W. C. Aspirin use and the risk for colorectal cancer and adenomas in male health professionals. Ann. Intern. Med., 121: 241-246, 1994.
49. Narisawa, T., Satoh, M., Sano, M., and Takahashi, T. Inhibition of initiation and promotion on N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroidal anti-inflammatory agent indomethacin. J. Japan Surg. Soc., 99: 362-367, 1998.
50. Pollard, M., and Luckert, P. H. Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. Cancer Lett., 25: 117-121, 1984.
51. Reddy, B. S., Rao, C. V., Rivenson, A., and Kelloff, G. J. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis (Lond.), 14: 1493-1497, 1993.
52. Reddy, B. S., Maruyama, H., and Kelloff, G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res., 47: 5340-5346, 1987.
53. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a non-steroidal antiinflammatory agent. Cancer Res., 55: 1464-1472, 1995.
54. Wargovich, M. J., Chem, C. D., Harris, C., Yang, E., and Valascom, M. Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int. J. Cancer, 60: 515-519, 1995.
55. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56: 710-714, 1996.
56. Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martucci, C., Guo, X. J., Ramonetti, J. T., Abreu-Goris, M., Newmark, H. L., Lipkin, M. L., DeCosse, J. J., and Bertagnolli, M. M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56: 2556-2560, 1996.
57. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
58. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., and Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995.
59. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110: 1259-1262, 1996.
60. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). J. Natl. Cancer Inst., 90: 1529-1536, 1998.
61. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J. Natl. Cancer Inst., 90: 1609-1620, 1998.
62. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
63. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon cancer. Cancer Res., 56: 4566-4569, 1996.
64. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58: 409-412, 1998.
65. Clark, L. C. The epidemiology of selenium and cancer. Fed. Proc., 44: 2584-2589, 1985.
66. Clark, L. C., Combs, G. F., Turnbull, B. W., State, E. H., Chalker, D. K., Chow, J., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L., Park, K., Sanders, B. B., Smith, C. L., and Taylor, J. R. Effect of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. J. Am. Med. Assoc., 276: 1957-1963, 1996.
67. Ip, C. Selenium inhibition of chemical carcinogenesis. Fed. Proc., 44: 2584-2589, 1985.
68. El-Bayoumy, K. The role of selenium in cancer prevention. In: V. T. Devita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer Prevention, pp. 1-15. Philadelphia: Lippincott, 1991.
69. Nayini, J. R., Sugie, S., El-Bayoumy, K., Rao, C. V., Rigotty, J., Sohn, O. S., and Reddy, B. S. Effect of dietary benzylselenocyanate on azoxymethane-induced colon carcinogenesis in male F344 rats. Nutr. Cancer, 15: 129-139, 1991.
70. El-Bayoumy, K., Chae, Y. H., Upadhyaya, P., Meschter, C., Cohen, L. A., and Reddy, B. S. Inhibition of 7,12-dimethylbenz[a]anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Cancer Res., 52: 2402-2407, 1992.
71. El-Bayoumy, K., Upadhyaya, P., Desai, B. H., Amin, S., and Hecht, S. S. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis (Lond.), 14: 1111-1113, 1993.
72. Reddy, B. S., Rivenson, A., Kulkarni, N., Upadhyaya, P., and El-Bayoumy, K. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Res., 52: 5635-5640, 1992.
73. Reddy, B. S., Rivenson, A., El-Bayoumy, K., Upadhyaya, P., Pittman, B., and Rao, C. V. Chemoprevention of colon cancer by synthetic organoselenium compounds, 1,4-phenylenebis(methylene)selenocyanate and p-methoxy benzyl selenocyanate, in low and/or high fat fed F344 rats. J. Natl. Cancer Inst., 89: 506-516, 1997.
74. Pegg, A. E. Polyamine metabolism and its importance in neoplastic growth and as a target as a chemotherapy. Cancer Res., 48: 759-774, 1988.
75. Takano, S., Matsushima, M., Erturk, E., and Byran, G. T. Early induction of rat colonic epithelial ornithine and S-adenosyl-L-methionine decarboxylase activities by N-methyl-N′-nitro-N-nitrosoguanidine or bile salts. Cancer Res., 41: 624-628, 1981.
76. Reddy, B. S., Nayini, J., Tokumo, K., Rigotty, J., Zang, E., and Kelloff, G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug, with D,L-α-difluoromethylornithine, an ornithine decarboxylase inhibitor in diet. Cancer Res., 50: 2562-2568, 1990.